Advances in Care Podcast - Episode 24
In today’s world, genetic testing has become increasingly accessible for more people, creating an increased opportunity for doctors to improve their patients' health. Dr. Melissa Frey, a gynecologic oncologist at NewYork-Presbyterian and Weill Cornell Medicine, is championing an approach known as “cascade genetic testing” to not only learn more about her patient’s cancer risk but to then be able to alert family members of their risk too. As a part of the Genetics and Personalized Cancer Prevention Program at Weill Cornell Medicine, she and her team ensure end-to-end care for all patients, including testing, counseling and coordination that helps a patient manage the multiple risks and conditions that they may face in an integrated effort.